Sutro slash­es work­force in half, changes CEO and clos­es fac­to­ry

Sutro Bio­phar­ma is re­duc­ing its head­count by 50%, ap­point­ing a new CEO, shut­ting down its on­ly fac­to­ry, and shift­ing away from its lead can­di­date. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.